We are live on ! Find out more
Westfield Capital Management

Westfield Capital Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 49.45%
This Fund
S&P 500
This Quarter Est. Return
+0.66%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$16.4B
AUM Growth
-$424M
Cap. Flow
-$337M
Cap. Flow %
-2.05%
Top 10 Hldgs %
18.17%
Holding
344
New
32
Increased
105
Reduced
137
Closed
45

Sector Composition

Rank Sector Weight
1 Healthcare 19.71%
2 Technology 14.97%
3 Industrials 13.61%
4 Consumer Discretionary 10.6%
5 Communication Services 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$485M 2.96%
19,269,348
+1,881,844
+11% +$46.2M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$3.9T
$388M 2.37%
13,366,618
+24,106
+0.2% +$697K
CELG
3
DELISTED
Celgene Corp
CELG
$364M 2.22%
3,842,483
-241,800
-6% -$21.8M
JAZZ icon
4
Jazz Pharmaceuticals
JAZZ
$16B
$321M 1.96%
1,996,359
+101,638
+5% +$15.6M
AGN
5
DELISTED
Allergan plc
AGN
$254M 1.55%
1,052,530
-401,432
-28% -$89.8M
TEVA icon
6
Teva Pharmaceuticals
TEVA
$36B
$252M 1.54%
4,687,525
-481,029
-9% -$25.5M
ANDV
7
DELISTED
Andeavor
ANDV
$237M 1.45%
3,882,336
+20,774
+0.5% +$1.28M
MSFT icon
8
Microsoft
MSFT
$2.85T
$228M 1.39%
4,920,499
+4,902,539
+27,297% +$219M
CBST
9
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$227M 1.39%
3,421,430
+186,860
+6% +$12.3M
TMO icon
10
Thermo Fisher Scientific
TMO
$212B
$221M 1.35%
1,813,475
-40,963
-2% -$4.98M
META icon
11
Meta Platforms (Facebook)
META
$1.52T
$218M 1.33%
2,759,268
+13,725
+0.5% +$1.01M
CMCSA icon
12
Comcast
CMCSA
$79.9B
$214M 1.31%
7,965,416
+465,696
+6% +$12.8M
COO icon
13
Cooper Companies
COO
$13.8B
$204M 1.25%
5,248,688
-608,348
-10% -$23.9M
ABBV icon
14
AbbVie
ABBV
$458B
$193M 1.18%
3,347,675
+611,870
+22% +$34M
BKNG icon
15
Booking.com
BKNG
$137B
$189M 1.15%
4,079,875
-15,425
-0.4% -$759K
CRM icon
16
Salesforce
CRM
$135B
$184M 1.13%
3,206,021
+186
+0% +$10.5K
AME icon
17
Ametek
AME
$55.4B
$180M 1.1%
3,577,219
-11,227
-0.3% -$583K
ENDP
18
DELISTED
Endo International plc
ENDP
$178M 1.08%
+2,599,669
New +$171M
NOV icon
19
NOV
NOV
$7.41B
$168M 1.02%
2,204,449
+3,168
+0.1% +$262K
V icon
20
Visa
V
$674B
$167M 1.02%
3,138,744
-14,600
-0.5% -$785K
HAL icon
21
Halliburton
HAL
$27.8B
$166M 1.01%
2,571,612
-8,736
-0.3% -$599K
DIS icon
22
Walt Disney
DIS
$165B
$163M 0.99%
1,829,795
-3,304
-0.2% -$291K
MON
23
DELISTED
Monsanto Co
MON
$158M 0.97%
1,408,530
-6,200
-0.4% -$725K
VZ icon
24
Verizon
VZ
$192B
$157M 0.96%
3,141,756
-319,968
-9% -$15.9M
TFCFA
25
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$152M 0.93%
+4,444,247
New +$154M

Similar funds

Westfield Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Westfield Capital Management held 344 positions worth $16.4B, down 2.5% from $16.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Westfield Capital Management's Q3 2014 filing shows 32 new, 105 increased, 137 reduced and 45 closed positions. Its largest new stake was Endo International plc: 2,599,669 shares worth $178M. The largest sale was Viacom Inc. Class B, an estimated $180M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

  • Westfield Capital Management's largest Q3 2014 buy was Endo International plc: 2,599,669 shares worth $178M.
  • Westfield Capital Management added most to Microsoft in Q3 2014, an estimated $219M increase.
  • Westfield Capital Management's biggest Q3 2014 reduction was American International, cutting an estimated $151M.
  • Westfield Capital Management fully exited Viacom Inc. Class B in Q3 2014, selling an estimated $180M.
  • Westfield Capital Management's ten largest holdings make up 18% of its $16.4B portfolio in Q3 2014.
  • Westfield Capital Management opened 32 new positions and closed 45 in Q3 2014.
  • Westfield Capital Management's portfolio value fell 2.5% quarter-over-quarter to $16.4B.

Based on Westfield Capital Management's 13F filing for Q3 2014, filed 12 Nov 2014.